Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma / Rupoli, S; Goteri, G; Morsia, E; Torre, E; Garvey, Kb; Giantomassi, F; Campanati, A; Offidani, Am; Brandozzi, G; Giorgio, M; Simonacci, M; Olivieri, A. - In: BLOOD. - ISSN 0006-4971. - 138:(2021), pp. 2462-2462. [10.1182/blood-2021-150633]
Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma
Rupoli, SPrimo
;Goteri, G;Morsia, E
;Torre, E;Garvey, KB;Giantomassi, F;Campanati, A;Offidani, AM;Olivieri, A
2021-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
